Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9.
Open Access
- 1 March 1986
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 136 (5) , 1777-1782
- https://doi.org/10.4049/jimmunol.136.5.1777
Abstract
Species-restricted lysis of complement refers to the relative inefficiency of complement to lyse cells from the homologous species. Restriction occurs at least at the steps involving C3/C5 convertase formation and the C9 insertion phase of the complement cascade, and is presumed to be mediated by inhibitory factors in the target cell membrane. In this study, we have examined whether decay accelerating factor (DAF), a membrane protein known to modulate C3/C5 convertase activities on cell surfaces, acts as a regulatory protein in species-restricted lysis of human erythrocyte (E). The role of DAF was assessed in homologous lysis by the classic pathway, in reactive lysis, and in lytic steps requiring C8 and C9. The results indicated that DAF participated in regulating C3/C5 deposition on the surface of homologous E, but had no effect on homologous restriction in reactive lysis and in the reaction of C8 and C9 with antibody-sensitized E C1-7. Treatment of E with pronase or with dithiothreitol (DTT) abolished the restricting effect of homologous C8/C9, indicating that species-restricted lysis by C5b-9 involves membrane factor(s) sensitive to pronase and DTT.This publication has 20 references indexed in Scilit:
- Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies.Proceedings of the National Academy of Sciences, 1982
- Homologous species restriction in lysis of erythrocytes by terminal complement proteins.Proceedings of the National Academy of Sciences, 1981
- Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyteThe Journal of Experimental Medicine, 1980
- Regulation by membrane sialic acid of β1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathwayProceedings of the National Academy of Sciences, 1978
- DIFFERENCES IN TERMINAL STEPS OF COMPLEMENT LYSIS OF NORMAL AND PAROXYSMAL NOCTURNAL HEMOGLOBINURIA RED-CELLS1978
- Lytic Activity of C5̄‑9̄ Complexes for Erythrocytes from the Species Other Than Sheep: C9 Rather Than C8-Dependent Variation in Lytic ActivityThe Journal of Immunology, 1977
- A New Activity of Complement Component C3: Cell-Bound C3b Potentiates Lysis of Erythrocytes by C5b,6 and Terminal ComponentsThe Journal of Immunology, 1976
- Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody.Journal of Clinical Investigation, 1966
- The Initiation and Enhancement of Human Red Cell Lysis by Activators of the First Component of Complement and by First Component Esterase; Studies Using Normal Red Cells and Red Cells from Patients with Paroxysmal Nocturnal Hemoglobinuria*Journal of Clinical Investigation, 1965
- THE PROPERDIN SYSTEM AND IMMUNITY. IV. THE HEMOLYSIS OF ERYTHROCYTES FROM PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 1Journal of Clinical Investigation, 1956